148 related articles for article (PubMed ID: 27655473)
1. Neurofibromatosis Type 2.
Ardern-Holmes S; Fisher G; North K
J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
Evans DG
Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
Subbotina MV; Berseneva AV
Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
[TBL] [Abstract][Full Text] [Related]
4. Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.
Evans DG; Kalamarides M; Hunter-Schaedle K; Blakeley J; Allen J; Babovic-Vuskanovic D; Belzberg A; Bollag G; Chen R; DiTomaso E; Golfinos J; Harris G; Jacob A; Kalpana G; Karajannis M; Korf B; Kurzrock R; Law M; McClatchey A; Packer R; Roehm P; Rubenstein A; Slattery W; Tonsgard JH; Welling DB; Widemann B; Yohay K; Giovannini M
Clin Cancer Res; 2009 Aug; 15(16):5032-5039. PubMed ID: 19671848
[TBL] [Abstract][Full Text] [Related]
5. Brainstem ischemic syndrome in juvenile NF2.
Henson JW; Benkers T; McCormick C
Neurol Genet; 2020 Aug; 6(4):e446. PubMed ID: 32637630
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 2 and related disorders.
Halliday D; Parry A; Evans DG
Curr Opin Oncol; 2019 Nov; 31(6):562-567. PubMed ID: 31425178
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1.
Cimino PJ; Gutmann DH
Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
[TBL] [Abstract][Full Text] [Related]
8. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
[TBL] [Abstract][Full Text] [Related]
9. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
[TBL] [Abstract][Full Text] [Related]
10. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
11. Facial Nerve Schwannomas: Review of 80 Cases Over 25 Years at Mayo Clinic.
Carlson ML; Deep NL; Patel NS; Lundy LB; Tombers NM; Lohse CM; Link MJ; Driscoll CL
Mayo Clin Proc; 2016 Nov; 91(11):1563-1576. PubMed ID: 27720200
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment in neurofibromatosis type 2. Review of the literature and presentation of clinical reports.
Goutagny S; Kalamarides M
Neurochirurgie; 2018 Nov; 64(5):370-374. PubMed ID: 28162254
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes.
Lu VM; Ravindran K; Graffeo CS; Perry A; Van Gompel JJ; Daniels DJ; Link MJ
J Neurooncol; 2019 Sep; 144(2):239-248. PubMed ID: 31254266
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
15. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Caltabiano R; Polizzi A
Childs Nerv Syst; 2017 Apr; 33(4):549-560. PubMed ID: 27669695
[No Abstract] [Full Text] [Related]
16. Neurofibromatosis and Schwannomatosis.
Plotkin SR; Wick A
Semin Neurol; 2018 Feb; 38(1):73-85. PubMed ID: 29548054
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 2: Hearing preservation and rehabilitation.
Jia H; El Sayed MME; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Neurochirurgie; 2018 Nov; 64(5):348-354. PubMed ID: 30314805
[TBL] [Abstract][Full Text] [Related]
18. An update on the diagnosis and treatment of vestibular schwannoma.
Halliday J; Rutherford SA; McCabe MG; Evans DG
Expert Rev Neurother; 2018 Jan; 18(1):29-39. PubMed ID: 29088993
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
